John A Orwin is PRESIDENT & CEO of Atreca, Inc.. Currently has a direct ownership of 1 shares of BCEL, which is worth approximately $0. The most recent transaction as insider was on Apr 11, 2024, when has been sold 1 shares (Series A Junior Preferred Stock) at a price of $0.01 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1
0% 3M change
100.0% 12M change
Total Value Held $0

John A Orwin Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 11 2024
BUY
Open market or private purchase
$0 $0.01 p/Share
1 Added 50.0%
1 Series A Junior Prefer...
Sep 01 2023
SELL
Open market or private sale
$8,491 $0.37 p/Share
22,951 Reduced 22.84%
77,541 Class A Common Stock
Sep 02 2022
SELL
Open market or private sale
$37,216 $1.78 p/Share
20,908 Reduced 17.22%
100,492 Class A Common Stock
Sep 09 2021
BUY
Grant, award, or other acquisition
-
115,400 Added 48.73%
121,400 Class A Common Stock

Also insider at

SGEN
Seagen Inc. Healthcare
TVTX
Travere Therapeutics, Inc. Healthcare
ANAB
ANAPTYSBIO, INC Healthcare
CRGX
CARGO Therapeutics, Inc.
JAO

John A Orwin

PRESIDENT & CEO
San Carlos, CA

Track Institutional and Insider Activities on BCEL

Follow Atreca, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCEL shares.

Notify only if

Insider Trading

Get notified when an Atreca, Inc. insider buys or sells BCEL shares.

Notify only if

News

Receive news related to Atreca, Inc.

Track Activities on BCEL